News and blogs
398 results found.
Brits don’t know blood cancer symptoms
Only 1 in 10 people are confident they know the common symptoms of blood cancer despite it being one of the most commonly diagnosed cancers in the UK.
Blood cancer patients may be denied CAR-T
Draft guidance by the NHS medicines watchdog recommends a new treatment that harnesses the immune system to fight cancer should not be available.
Blood cancer patients least likely to understand their diagnosis
How MPN disrupt work of blood stem cells
Blood Cancer UK researchers discover blood stem cells need to strike a delicate balance between making other types of blood cells and renewing themselves.
CLL - more people to benefit from ibrutinib in future
More people living with a type of leukaemia in England will soon have access to Ibrutinib, thanks to a successful campaign by Blood Cancer UK.
DLBCL took my partner
The story of my partner Mark and his battle with the bastard blood cancer that is Diffuse large B-cell non-Hodgkin lymphoma (DLBCL)
Blood cancers have longer diagnosis
A survey of patients treated for cancer on the NHS in England shows that blood cancers are still taking longer to be diagnosed than other types of cancer.
Blood cancer research breakthroughs
We look back on some of the biggest developments in blood cancer research that have led to improved NHScare for people with blood cancer.
Stem cell transplants without chemotherapy?
One option for treating or even curing blood cancers is a stem cell transplant. What if there was a less toxic way to get rid of these stem cells?
Leukaemia risk: babies with Down's syndrome
Professor Irene Roberts explains why new guidelines are needed to identify those children with Down's syndrome at risk of developing leukaemia.
New drug to improve leukaemia survival rates
A targeted cancer drug that reduces the chances of relapse for people with an aggressive type of leukaemia will be made available on the NHS in Scotland.
Genetic mutation 'likely cause' of childhood leukaemia
Blood Cancer UK-funded researchers say genetic mutation followed by infection is the most likely cause of the most common type of childhood leukaemia.
Blood cancer patients potentially losing access to crucial drugs
People with blood cancer risk being denied access to crucial treatments because of restrictions imposed by NHS England on the use of cancer medicines.
Three types of blood cancer treatment approved by NICE
NICE approves treatment for three types of blood cancer which will become routinely available on the NHS for people in England.
Chimeric antigen receptor T-cell therapy (CAR-T) could be made available on the NHS
Chimeric antigen receptor T-cell therapy (CAR-T) could be made available on the NHS this year.
British Society for Haematology Annual Meeting 2018 highlights
I spent 3 days at the British Society for Haematology Annual Meeting in Liverpool with Blood Cancer UK research team. Read about some exciting studies.
MP Jess Phillips meets top leukaemia scientists
The Birmingham Yardley MP met Professor Paul Moss and his team at the Institute of Immunology and Immunotherapy before World AML Awareness Day.
Scientists granted over £500,000 to tackle acute myeloid leukaemia AML
Two research projects are underway at the University of Cambridge that are seeking to find new ways to treat acute myeloid leukaemia (AML).
A seat is so important when you have blood cancer
Why getting seat on the tube can be so important if you have blood cancer
Childhood leukaemia - scientists map the genetic evolution
Key genetic events responsible for initiating the early stages of a type of childhood leukaemia have been identified by scientists in London.